Most of the world`s supply of {sup 99m}Tc for medical purposes is currently produced form the decay of {sup 99}Mo derived from the fissioning of high-enriched uranium (HEU). Substitution of low-enriched uranium (LEU) metal foils for the HEU UO{sub 2} used in current target designs will allow equivalent {sup 99}Mo yields with little change in target geometries. Substitution of uranium metal for uranium alloy and aluminide in other target designs will also allow the conversion of HEU to LEU. Several uranium-metal-foil targets have been fabricated at ANL and irradiated to prototypic burnup in the Indonesian RSG-GAS reactor. Postirradiation examination of the initial test indicated that design modifications were required to allow the irradiated...
Presented here are recent experimental results of our continuing development activities associated w...
A process is under development to use low-enriched uranium (LEU) metal targets for production of {su...
The first step in processing low-enriched uranium (LEU) targets for production of {sup 99}Mo is to d...
Most of the world`s supply of {sup 99m}Tc for medical purposes is currently produced from the decay ...
Most of the world`s supply of {sup 99m}Tc for medical purposes is currently produced from the decay ...
Most of the world's supply of 99mTc for medical purposes is currently produced from the decay o...
Currently much of the world's supply of /sup 99m/Tc for medical purposes is produced from /sup 99/Mo...
Argonne National Laboratory is cooperating with the National Atomic Energy Commission of the Argenti...
In March and September 1999, demonstrations of the irradiation, disassembly, and processing of LEU m...
During 1998, the emphasis of our activities was focused mainly on target fabrication. Successful con...
The irradiation, disassembly, and processing of two full-scale low-enriched uranium (LEU) targets we...
Over this past year, extraordinary progress has been made in executing our charter to assist in conv...
This paper discusses efforts towards LEU substitution in two HEU targets. One type is the Cintichem ...
Presented here are recent experimental results of the continuing development activities associated w...
Technetium-99m is a radiopharmaceutical currently used in 85 % of all diagnostic imaging procedures....
Presented here are recent experimental results of our continuing development activities associated w...
A process is under development to use low-enriched uranium (LEU) metal targets for production of {su...
The first step in processing low-enriched uranium (LEU) targets for production of {sup 99}Mo is to d...
Most of the world`s supply of {sup 99m}Tc for medical purposes is currently produced from the decay ...
Most of the world`s supply of {sup 99m}Tc for medical purposes is currently produced from the decay ...
Most of the world's supply of 99mTc for medical purposes is currently produced from the decay o...
Currently much of the world's supply of /sup 99m/Tc for medical purposes is produced from /sup 99/Mo...
Argonne National Laboratory is cooperating with the National Atomic Energy Commission of the Argenti...
In March and September 1999, demonstrations of the irradiation, disassembly, and processing of LEU m...
During 1998, the emphasis of our activities was focused mainly on target fabrication. Successful con...
The irradiation, disassembly, and processing of two full-scale low-enriched uranium (LEU) targets we...
Over this past year, extraordinary progress has been made in executing our charter to assist in conv...
This paper discusses efforts towards LEU substitution in two HEU targets. One type is the Cintichem ...
Presented here are recent experimental results of the continuing development activities associated w...
Technetium-99m is a radiopharmaceutical currently used in 85 % of all diagnostic imaging procedures....
Presented here are recent experimental results of our continuing development activities associated w...
A process is under development to use low-enriched uranium (LEU) metal targets for production of {su...
The first step in processing low-enriched uranium (LEU) targets for production of {sup 99}Mo is to d...